Read/Search this Article
Abstract
Previous study on in vitro antiplasmodial activity of diaza phenanthrene analogs indicated that the 1, 10-phenanthroline skeleton represents a potential antimalarial leader compound. Based on those skeletons, six derivatives of N-alkyl and N-benzyl-1, 10-phenanthroline were synthesized and the in vitro antiplasmodial activities was evaluated. This paper reported the in vivo antiplasmodial activity study of the 1, 10-phenanthroline derivatives performed by the classical 4-day suppressive test against Plasmodium berghei. Acute toxicity of each compound was determined after a single injection of the compound intraperitoneally in Swiss mice. The 50% effective dose (ED_<50>) of the compound ranged from 2.08 to 50.93mg/kg of body weight, and the therapeutic indices (TIs) ranged from 2.06 to 7.57 except (1)-N-benzyl-1, 10-phenantrolinium iodide, which was 58.38. All of the 1, 10-phenanthroline derivatives had in vivo antiplasmodial activity and (1)-N-benzyl-1, 10-phenantrolinium iodide was the most potent.
Journal
- Journal of health science [List of Volumes]
-
Journal of health science 52(6), 794-799, 2006-12-01 [Table of Contents]
The Pharmaceutical Society of Japan